ten23 health collaborates with Ypsomed to market a new patch injector
ten23 health (based in Basel and at BioArk Visp) and Ypsomed announced that they are entering into a strategic partnership to advance thecommercialization of the YpsoDose wearable injector for subcutaneous self-injection of large-volume doses.
ten23 health collaborates with Ypsomed to market a new patch injector Read More »












